Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bausch Health Companies Inc. | Director | Common Shares, No Par Value | 1.43M | $11.4M | $8.02 | May 10, 2022 | Direct |
Bausch & Lomb Corp | CEO & Chairman, Director | Common Shares, No Par Value | 472K | $8.06M | $17.06 | May 5, 2022 | Direct |
Emergent BioSolutions Inc. | President and CEO, Director | Common Stock | 0 | $0 | $2.74 | Feb 21, 2024 | Direct |
Bausch & Lomb Corp | CEO & Chairman, Director | Non-Qualified Stock Options (right to purchase) | 1.87M | May 5, 2022 | Direct | ||
Emergent BioSolutions Inc. | President and CEO, Director | Employee Stock Options (Right to Buy) | 750K | Mar 13, 2024 | Direct | ||
Milestone Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 80K | Sep 3, 2024 | Direct | ||
Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.2K | Jun 26, 2024 | Direct | ||
Bausch Health Companies Inc. | Director | Restricted Share Units | 0 | $9.40 | May 10, 2022 | Direct | |
Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | By The Papa Family Charitable Trust | |
Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | Direct | |
Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | Jun 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MIST | Milestone Pharmaceuticals Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
MIST | Milestone Pharmaceuticals Inc. | Sep 3, 2024 | 0 | $0 | 3 | Sep 5, 2024 | Director |
CADL | Candel Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
EBS | Emergent BioSolutions Inc. | Mar 13, 2024 | 1 | $0 | 4 | Mar 15, 2024 | President and CEO, Director |
EBS | Emergent BioSolutions Inc. | Feb 21, 2024 | 0 | $0 | 3 | Feb 29, 2024 | President and CEO, Director |
CADL | Candel Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
RXDX | Prometheus Biosciences, Inc. | Jun 16, 2023 | 7 | $0 | 4 | Jun 16, 2023 | Director |
RXDX | Prometheus Biosciences, Inc. | Jun 2, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
RXDX | Prometheus Biosciences, Inc. | May 19, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
CADL | Candel Therapeutics, Inc. | Dec 8, 2022 | 2 | $73.1K | 4 | Dec 12, 2022 | Director |
CADL | Candel Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 10, 2022 | Director |
CADL | Candel Therapeutics, Inc. | Aug 8, 2022 | 0 | $0 | 3 | Aug 10, 2022 | Director |
RXDX | Prometheus Biosciences, Inc. | May 19, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
BHC | Bausch Health Companies Inc. | May 10, 2022 | 10 | -$3.76M | 4 | May 12, 2022 | Director |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 2 | $0 | 4 | May 9, 2022 | CEO & Chairman, Director |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Chief Executive Officer and Chairman Exhibit 24 - Power of Attorney, Director |
BHC | Bausch Health Companies Inc. | Mar 3, 2022 | 1 | -$299K | 4 | Mar 7, 2022 | CHAIRMAN & CEO, Director |
BHC | Bausch Health Companies Inc. | Feb 26, 2022 | 7 | -$8.28M | 4 | Mar 2, 2022 | Chairman & CEO, Director |
RXDX | Prometheus Biosciences, Inc. | Nov 14, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Director |
BHC | Bausch Health Companies Inc. | Sep 13, 2021 | 2 | -$247K | 4 | Sep 15, 2021 | CHAIRMAN & CEO, Director |